Search Filters

Search Results

Found 3 results

510(k) Data Aggregation

    K Number
    K231754
    Manufacturer
    Date Cleared
    2023-07-13

    (28 days)

    Product Code
    Regulation Number
    880.5200
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Praxiject™ 0.9% NaCl

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Praxiject™ 0.9% NaCl prefilled syringe with 0.9% Sodium Chloride Injection, USP, is intended only for flushing vascular access devices. May be placed on a sterile field.

    Device Description

    The Praxiject™ family of 0.9% NaCl prefilled syringes marketed in the U.S.A. includes the following models: 37043US (3 mL/5 cc), 3704US (5 mL/5 cc), 37053US (3 mL/10 cc), 37055 US (5 mL/10 cc), 3705CUS (10 mL/10 cc), 3705-1US (10 mL/10 cc) and 3706US (20 mL/20 cc). These devices are single use plastic piston syringes with a Luer lock connection fitting, prefilled to labeled volume with 0.9% Sodium Chloride Injection USP, with no preservatives (normal saline), and capped with a plastic tip cap. Model 3705-1US (10 mL/10 cc) is individually packaged in a heat-sealed foil pouch, all other models are individually packaged in a heat-sealed peel pouch. All Praxiject™ 0.9% NaCl prefilled syringes are terminally sterilized by gamma irradiation.

    AI/ML Overview

    The provided document is a 510(k) Pre-Market Notification for a medical device called Praxiject™ 0.9% NaCl, which is a prefilled saline flush syringe. The purpose of this notification is to demonstrate that the modified device is substantially equivalent to legally marketed predicate devices.

    The document does not describe a study involving an AI/ML device, a "test set" of data, or "ground truth" as typically understood in the context of evaluating AI/ML performance. Instead, it details the analytical and performance testing conducted for a physical medical device to ensure its safety and effectiveness.

    Therefore, many of the requested categories (2, 3, 4, 5, 6, 7, 8, 9) are not applicable to this document as they are specific to AI/ML device evaluation.

    However, I can extract information related to acceptance criteria and device performance based on the non-clinical testing summary.

    1. A table of acceptance criteria and the reported device performance

    The document provides a comprehensive table of "Device Specification," "Standard," and "Acceptance Criteria" under the "Summary of Non-Clinical Testing" section. The "reported device performance" is implicitly stated as meeting these acceptance criteria, as the conclusion states, "The conclusions drawn from the non-clinical testing demonstrate that the modified Praxiject™ 0.9% NaCl prefilled syringe, is as safe, as effective, and performs as well as or better than the legally marketed primary predicate device." This implies all listed acceptance criteria were met.

    Here is a summary of the acceptance criteria:

    Device SpecificationStandardAcceptance Criteria
    Piston Syringe Testing (Each production lot)
    Design and Performance RequirementsISO 7886-1; ISO 80369-7 (ISO 594-1 and ISO 594-2)Conformity to standards and device specifications
    Finished Device Testing (Each production lot)
    Appearance of SolutionUSP / Visual inspectionClear and colorless; Free of visible foreign solid particles
    Solution VolumeISO 7886-1, USP3 mL in 5 cc syringe: 3.0–3.4 mL
    3 mL in 10 cc syringe: 3.0-3.6 mL
    5 mL in 5 cc syringe: 5.0-5.6 mL
    5 mL in 10 cc syringe: 5.0-6.0 mL
    10 mL in 10 cc syringe: 10.0–11.0 mL
    20 mL in 20 cc syringe: 20.0-22.0 mL
    AssayUSP Sodium Chloride Injection0.855 - 0.945% (w/v)
    IdentificationUSP Sodium and ChlorideMeets USP requirements
    Bacterial EndotoxinsUSP , USP≤ 0.5 USP EU/mL
    Particulate MatterUSPParticles ≥ 10 µm: ≤ 6000/syringe;
    Particles ≥ 25 µm: ≤ 600/syringe
    pHUSP4.5 - 7.0
    Elemental ImpuritiesUSP and USP (Class I elements)Arsenic:
    Syringe Closure IntegrityISO 7886-1, ISO 594-2 (Adapted solution leakage test)No damage, no leakage past piston and syringe tip cap
    Pouch IntegrityASTM D3078 (Vacuum bubble emissions test)No stream of bubbles; no leaks
    Sterility and Shelf-life Testing (Design Verification and Validation)
    Sterility of Solution and Syringe ExteriorUSPSterile
    Sterilization Method ValidationISO 11137-1, ISO 11137-2, USP (Terminal sterilization by gamma radiation)SAL 10-6
    Shelf-life (Stability Study)FDA Guidance: Shelf Life of Medical Devices (1991); FDA Guidance: Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products (2003)Device specifications must be maintained for the labeled shelf life
    Distribution Simulation Testing (Design Verification and Validation)
    Device & Package IntegrityASTM D4169 (Distribution Cycle 13, Assurance Level II); ISO 11607-1; ASTM F1886 (Visual seal integrity verification); ASTM D3078 (Vacuum bubble emissions test); ISO 7886-1 and ISO 594-2 (Syringe and tip cap integrity verification)No structural damage to shipping carton;
    Pouch/seal integrity - No seal defects; no stream of bubbles and no leaks during vacuum bubble emissions testing;
    Syringe integrity - No critical damage, no leaks past syringe cap or gasket;
    Luer lock (tip cap) connection - No cracks, no leaks
    Biocompatibility Testing (Design Verification and Validation)
    Biological EvaluationISO 10993-1; FDA Guidance: Use of International Standard ISO 10993-1, Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process (2020)Compliant process and evaluation for external communicating devices intended for indirect blood path contact with limited duration
    Chemical Characterization (Extractables/Leachables)ISO 10993-18, ISO 10993-17 USPAcceptable extractables/leachables profile; Negligible risk of health hazard
    CytotoxicityISO 10993-5Non-cytotoxic
    SensitizationISO 10993-10Non-sensitizer
    IrritationISO 10993-23Non-irritant
    HemolysisISO 10993-4 (ASTM F756)Non-hemolytic
    Acute Systemic ToxicityISO 10993-11Non-toxic
    PyrogenicityISO 10993-11 (USP )Non-pyrogenic

    2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    This information is not provided in a way that is applicable to an AI/ML "test set." The document describes non-clinical testing of a physical device. While specific sample sizes and testing methodologies are implied by the listed standards (e.g., ISO, ASTM, USP), the exact sample sizes for each test are not explicitly enumerated in this summary. Data provenance, in terms of country of origin or retrospective/prospective collection, is not relevant for this type of device submission.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    Not applicable. "Ground truth" and "experts" are terms used in the context of evaluating diagnostic AI/ML models. This document describes the physical and chemical testing of a medical device.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. This refers to methods for resolving discrepancies in expert interpretations, which is not relevant for physical device testing.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This is a type of study specifically for evaluating AI/ML diagnostic tools.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This refers to the standalone performance of an AI/ML algorithm.

    7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)

    Not applicable. The "ground truth" for this device's performance is objective measurements against established international and USP standards for product quality, safety, and performance (e.g., pH, sterility, particle count, leakage, biocompatibility).

    8. The sample size for the training set

    Not applicable. This concept pertains to AI/ML model development.

    9. How the ground truth for the training set was established

    Not applicable. This concept pertains to AI/ML model development.

    Ask a Question

    Ask a specific question about this device

    K Number
    K192414
    Manufacturer
    Date Cleared
    2020-02-13

    (162 days)

    Product Code
    Regulation Number
    880.5200
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Praxiject 0.9% NaCl

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Praxiject™ 0.9% NaCl prefilled syringe with 0.9% Sodium Chloride Injection, USP, is intended only for flushing vascular access devices. May be placed on a sterile field.

    Device Description

    The Praxiject™ 0.9% NaCl prefilled syringe is a single use plastic piston syringe with a Luer lock connection fitting, prefilled to labeled volume with 0.9% Sodium Chloride Injection, USP, with no preservatives (normal saline), and capped with a plastic tip cap. Each prefilled syringe is individually packaged in a heat-sealed pouch and terminally sterilized by gamma irradiation.

    AI/ML Overview

    The provided text is a 510(k) summary for the Praxiject™ 0.9% NaCl prefilled syringe, a medical device. It describes the device, its intended use, and comparative non-clinical testing performed to demonstrate substantial equivalence to a predicate device.

    Here's the information extracted from the document regarding acceptance criteria and the study that proves the device meets them:

    1. A table of acceptance criteria and the reported device performance:

    Test Methodology / StandardPurposeAcceptance CriteriaResults
    Visual inspection of pouch seals per ASTM F1886To verify pouch seal integrityNo visible unsealed areas, channels/pathway across width of seal, tears/holes: Reject on detection. Undersealed areas, oversealed areas (hard/brittle seal), narrow seals: non defective seal width should be greater than 67% of nominal seal width.Conforms
    Bubble emission test of pouch per ASTM D3078To verify the integrity of the product packaging (pouch)No leaks (no bubbles emitted upon immersion, no fluid inside the package).Conforms
    Visual inspection of prefilled syringe for damageTo ensure the prefilled syringe is not damaged in a way that would prevent its useNo critical damage (consistent with instructions for use); no leaks.Conforms
    Test for liquid leakage and resistance of luer lock fittingTo ensure the prefilled syringe is adequately sealedNo leaks; no cracks.Conforms
    Test for integrity of printed label per ASTM F2250To verify the integrity of the printed information is adequate for the intended use environmentPrint must remain defined and legible, color must not lighten, ink must not run (Slight smudging of ink or transfer to swab is allowable).Conforms
    Test of formulation per Sodium Chloride Injection USP monograph:To verify formulation of the Sodium Chloride solution meets the USP requirementsAssay of Sodium Chloride: 0.855 to 0.945% NaClConforms
    - pH per USPpH: 4.5 to 7.0Conforms
    - Identification of Sodium and Chloride per USPIdentification: Successful identificationConforms
    - Particulate matter per USPParticulate matter: ≥ 10μm: ≤ 6000 part/syringe; ≥ 25μm: ≤ 600 part/syringeConforms
    - Bacterial Endotoxins per USPBacterial Endotoxins: ≤ 0.5 EU/mLConforms
    - Elemental Impurities (Heavy Metals) per USP/ (Class I elements)Elemental Impurities: Arsenic: ≤ 1.5μg/g; Cadmium: ≤ 0.2μg/g; Mercury: ≤ 0.3μg/g; Lead: ≤ 0.5μg/gConforms
    - Iron per USPIron: ≤ 2ppmConforms
    Distribution cycle (Transport) Validation per ASTM D4169, Distribution Cycle 13To ensure the packaging maintains product integrity under anticipated shipping and handling conditionsPackaging and syringe integrity per ISO 11607-1Conforms
    Sterilization ValidationTo establish the minimum irradiation dose required to render the product sterile10-6 SAL per ISO 11137-2Conforms

    2. Sample size used for the test set and the data provenance:

    The document does not explicitly state the specific sample sizes used for each individual test. It lists "non-clinical testing" as the study type. The reference to standards like ASTM and USP monographs implies that the testing was performed on physical samples of the device and its packaging.

    • Data Provenance: The tests are described as "non-clinical testing" performed by MedXL Inc. The country of origin of the data is not specifically stated, but the manufacturer's address is in Pointe-Claire, Quebec, Canada. The data is retrospective as it was performed prior to the submission of the 510(k).

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    This information is not applicable. The studies performed are non-clinical (physical and chemical tests) and do not involve human interpretation or the establishment of ground truth by experts in a clinical context. The "ground truth" is determined by the results of the standardized tests against their defined acceptance criteria.

    4. Adjudication method for the test set:

    Not applicable. This concept applies to studies involving human interpretation or subjective assessments, which is not the case for these non-clinical tests.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    Not applicable. This is a non-clinical device (prefilled saline syringe) and does not involve AI assistance, human readers, or clinical effectiveness studies in this context.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    Not applicable. This device does not involve algorithms or AI.

    7. The type of ground truth used:

    The "ground truth" for the non-clinical tests is established by pre-defined, objective acceptance criteria derived from recognized industry standards (ASTM, ISO) and pharmaceutical monographs (USP). For example, the definition of an acceptable seal, specific chemical concentrations, or maximum particulate matter levels.

    8. The sample size for the training set:

    Not applicable. This device is not an AI/ML device, so there is no training set in the conventional sense.

    9. How the ground truth for the training set was established:

    Not applicable. As there is no training set, this question is not relevant.

    Ask a Question

    Ask a specific question about this device

    K Number
    K171109
    Manufacturer
    Date Cleared
    2017-12-21

    (251 days)

    Product Code
    Regulation Number
    880.5200
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Praxiject 0.9% NaCl

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Praxiject™ 0.9% NaCl prefilled syringe with 0.9% Sodium Chloride Injection, USP, is intended only for flushing vascular access devices. May be placed on a sterile field.

    Device Description

    The Praxiject™ 0.9% NaCl prefilled syringe is a single use plastic piston syringe with a Luer lock connection fitting, prefilled to labeled fill volume with 0.9% Sodium Chloride Injection, USP, with no preservatives (normal saline), and capped with a plastic tip cap. Each prefilled syringe is individually packaged in a plastic peel pouch and terminally sterilized by gamma irradiation.

    AI/ML Overview

    This document is a 510(k) Pre-market Notification for a medical device called Praxiject™ 0.9% NaCl, which is a prefilled syringe. This type of submission focuses on demonstrating substantial equivalence to a legally marketed predicate device, rather than proving the device meets specific performance criteria through clinical studies or AI algorithm validation studies.

    Therefore, many of the requested details about acceptance criteria, study types, sample sizes, and expert ground truth are not applicable to this document as it pertains to a traditional medical device (a prefilled syringe) and not an AI/ML-driven diagnostic or treatment device.

    Here's an analysis based on the provided document:

    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not explicitly present "acceptance criteria" in the context of an AI algorithm's performance metrics (e.g., sensitivity, specificity, AUC). Instead, it presents performance standards and results for the physical and chemical characteristics of the prefilled syringe.

    Device / Performance CharacteristicPerformance StandardReported Device Performance (Results)
    SolutionSodium Chloride Injection, USP 39-NF34Conforms
    Plastic syringeISO 7886-1, 0 mL average syringe induced refluxConforms
    Biocompatibility - HemolysisISO 10993-4 (ASTM F756)Non-hemolytic
    Biocompatibility - CytotoxicityISO 10993-5Non-cytotoxic
    Biocompatibility - SensitizationISO 10993-10Non-sensitizer
    Biocompatibility - Irritation/Intracutaneous reactivityISO 10993-10Non-irritant
    Biocompatibility - Acute system toxicityISO 10993-11No systemic toxicity
    Biocompatibility - Material—mediated pyrogenityISO 10993-11 (USP )No material mediated response observed
    Biocompatibility - Bacterial EndotoxinsUSP and USP (≤ 0.5 EU/mL)Conforms
    Biocompatibility - Chemical characterizationISO 10993-18Acceptable extractables/leachables profile
    Biocompatibility - Particulate matterUSPConforms
    Shelf lifeISO 11607-12 years (mentioned in comparison table, not directly in performance results table but implied by "evaluated using the recognized consensus standard")

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Not applicable. This document describes testing for a physical medical device (syringe), not an AI algorithm. The "test set" would refer to samples of the manufactured syringes and their components, tested in a laboratory setting according to the listed standards. There is no mention of "country of origin of the data" or "retrospective/prospective" as these pertain to clinical data for AI/ML validation.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • Not applicable. Ground truth in the context of this document refers to established standards and laboratory measurements for chemical and physical properties, not expert clinical interpretation. The "experts" would be laboratory technicians and chemists performing the tests according to standardized protocols.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    • Not applicable. This concept pertains to resolving discrepancies among expert readers in AI/ML validation studies. For direct physical and chemical testing, the results are typically objectively measured against pre-defined specifications in the performance standards.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • Not applicable. This is a traditional medical device (syringe), not an AI/ML system, so such a study would not be performed.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

    • Not applicable. This is a physical device, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    • The "ground truth" for this device's performance is established by conformance to recognized consensus standards (e.g., USP, ISO standards) and laboratory testing methods that define acceptable ranges and limits for physical, chemical, and biological properties. This is an objective, standardized ground truth based on scientific principles and established testing methodologies.

    8. The sample size for the training set

    • Not applicable. This is a physical medical device. There is no "training set" in the context of this 510(k) submission.

    9. How the ground truth for the training set was established

    • Not applicable. As there is no training set for an AI algorithm, this question does not apply.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1